1. The complications of MMR vaccinations: allaying the anxiety

   Newsletter Article 06 February 2013 Pages: 2 - 2

2. A change to human insulin may reduce the warning signs of hypoglycaemia

   Newsletter Article 06 February 2013 Pages: 2 - 3

3. The new tricyclic antidepressant on the block: amoxapine

   Newsletter Article 06 February 2013 Pages: 3 - 3

4. Nifedipine and glycaemic control in diabetic patients

   Newsletter Article 06 February 2013 Pages: 3 - 3

5. Alclofenac

   Newsletter Article 06 February 2013 Pages: 3 - 3

6. Allopurinol

   Newsletter Article 06 February 2013 Pages: 3 - 4

7. Alteplase

   Newsletter Article 06 February 2013 Pages: 4 - 4

8. Aminophylline/theophylline

   Newsletter Article 06 February 2013 Pages: 4 - 4

9. Amoxicillin

   Newsletter Article 06 February 2013 Pages: 4 - 4

10. Anabolic steroid abuse

    Newsletter Article 06 February 2013 Pages: 4 - 4

11. Antiarrhythmics

    Newsletter Article 06 February 2013 Pages: 4 - 4

12. Anti-infectives

    Newsletter Article 06 February 2013 Pages: 4 - 4

13. Benzodiazepines

    Newsletter Article 06 February 2013 Pages: 4 - 4

14. Calcium antagonists see Verapamil/calcium antagonists

    Newsletter Article 06 February 2013 Pages: 4 - 4

15. Ceftriaxone

    Newsletter Article 06 February 2013 Pages: 4 - 4

16. Chlorpromazine

    Newsletter Article 06 February 2013 Pages: 4 - 4

17. Cocaine abuse

    Newsletter Article 06 February 2013 Pages: 4 - 5

18. Cotrimoxazole/phenazopyridine

    Newsletter Article 06 February 2013 Pages: 5 - 5

19. Erythromycin

    Newsletter Article 06 February 2013 Pages: 5 - 5

20. Estradiol

    Newsletter Article 06 February 2013 Pages: 5 - 5

21. Ethinylestradiol

    Newsletter Article 06 February 2013 Pages: 5 - 6

22. Fluorouracil

    Newsletter Article 06 February 2013 Pages: 6 - 6

23. Fluoxetine

    Newsletter Article 06 February 2013 Pages: 6 - 6

24. Haloperidol see Lithium interaction

    Newsletter Article 06 February 2013 Pages: 6 - 6

25. Interferon alpha 2A/interferon alpha 2B

    Newsletter Article 06 February 2013 Pages: 6 - 7

26. Interferon alpha 2B see Interferon alpha 2A/interferon alpha 2B

    Newsletter Article 06 February 2013 Pages: 7 - 7

27. Interleukin 2

    Newsletter Article 06 February 2013 Pages: 7 - 7

28. Lithium interaction

    Newsletter Article 06 February 2013 Pages: 7 - 7

29. Medroxyprogesterone

    Newsletter Article 06 February 2013 Pages: 7 - 7

30. Mercaptopurine

    Newsletter Article 06 February 2013 Pages: 7 - 7

31. Metronidazole

    Newsletter Article 06 February 2013 Pages: 7 - 8

32. Mezlocillin

    Newsletter Article 06 February 2013 Pages: 8 - 8

33. Narcotics

    Newsletter Article 06 February 2013 Pages: 8 - 8

34. Nicotine poisoning

    Newsletter Article 06 February 2013 Pages: 8 - 8

35. Octreotide

    Newsletter Article 06 February 2013 Pages: 8 - 8

36. Paracetamol

    Newsletter Article 06 February 2013 Pages: 8 - 8

37. Pentamidine

    Newsletter Article 06 February 2013 Pages: 8 - 9

38. Phencyclidine overdose

    Newsletter Article 06 February 2013 Pages: 9 - 9

39. Phenobarbital/primidone

    Newsletter Article 06 February 2013 Pages: 9 - 10

40. Phenazopyridine see Cotrimoxazole/phenazopyridine

    Newsletter Article 06 February 2013 Pages: 10 - 10

41. Prednisolone

    Newsletter Article 06 February 2013 Pages: 10 - 10

42. Primidone see Phenobarbital/primidone

    Newsletter Article 06 February 2013 Pages: 10 - 10

43. Sodium cromoglycate

    Newsletter Article 06 February 2013 Pages: 10 - 10

44. Sulpiride

    Newsletter Article 06 February 2013 Pages: 10 - 10

45. Terfenadine

    Newsletter Article 06 February 2013 Pages: 10 - 10

46. Theophylline see Aminophylline/theophylline

    Newsletter Article 06 February 2013 Pages: 10 - 10

47. Thiamazole

    Newsletter Article 06 February 2013 Pages: 10 - 10

48. Thiamylal sodium

    Newsletter Article 06 February 2013 Pages: 10 - 11

49. Thiazide diuretics

    Newsletter Article 06 February 2013 Pages: 11 - 11

50. Thrombin

    Newsletter Article 06 February 2013 Pages: 11 - 11